Results 171 to 180 of about 983 (198)

Solriamfetol Real World Experience Study (SURWEY): Initiation and Titration Strategies Among Physicians Prescribing Solriamfetol for Patients with Narcolepsy from Germany

Sleep Medicine, 2022
Y. Winter, U. Kallweit, S. Kotterba, H. Benes, L. Burghaus, A. Koch, D. Girfoglio, M. Setanoians, G. Mayer   +8 more
openaire   +1 more source

Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials

Sleep Medicine, 2021
Heng Gao
exaly  

Comparison of Solriamfetol and Modafinil on Arousal and Anxiety-Related Behaviors in Narcoleptic Mice

Neurotherapeutics, 2022
Noriaki Sakai, Seiji Nishino
exaly  

Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea

Sleep, 2020
Atul Malhotra, Nancy Foldvary-Schaefer, Patrick J Strollo Jr   +2 more
exaly  

Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy

Sleep Medicine, 2020
Giuseppe Plazzi, yves Dauvilliers
exaly  

Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea

Human Psychopharmacology, 2022
Frederick R J Vinckenbosch, Jerryll Asin, Sebastiaan Overeem   +2 more
exaly  

Effects of Solriamfetol on Driving Performance in Participants With Narcolepsy (2274)

Neurology, 2021
Frederick Vinckenbosch, Gert Jan Lammers, Sebastiaan Overeem, Dan Chen, Grace Wang, Lawrence Carter, Kefei Zhou, Johannes G. Ramaekers, Annemiek Vermeeren   +8 more
openaire   +1 more source

Trial suggests effectiveness of solriamfetol for adult ADHD

The Brown University Psychopharmacology Update, 2023
openaire   +1 more source

Stability Indicating RP-HPLC-PDA Method for the Quantification of Solriamfetol in Bulk and Marketed Dosage Form

Pharmaceutical Chemistry Journal, 2023
Gowri Gollu, Sowjanya Gummadi, Lekya Gurijala   +2 more
semanticscholar   +1 more source

A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

Journal of Psychopharmacology, 2018
Yuan Lu
exaly